OPIOIDS, SUBSTANCE ABUSE & ADDICTIONS SECTION Original Research Article Dose Patterns among Patients Using Low-Dose Buprenorphine Patches

[1]  K. Lyseng-Williamson,et al.  Buprenorphine 5,10 and 20 μg/h Transdermal Patch: A Guide to Its Use in Chronic Non-Malignant Pain , 2012, CNS Drugs.

[2]  N. Al-Tawil,et al.  Pharmacokinetics of transdermal buprenorphine patch in the elderly , 2012, European Journal of Clinical Pharmacology.

[3]  S. Kaasa,et al.  Low‐dose transdermal buprenorphine – long‐term use and co‐medication with other potentially addictive drugs , 2012, Acta anaesthesiologica Scandinavica.

[4]  S. Studenski,et al.  Analgesic use for knee and hip osteoarthritis in community-dwelling elders. , 2011, Pain medicine.

[5]  N. Mekhail,et al.  Age-dependent intrathecal opioid escalation in chronic noncancer pain patients. , 2011, Pain medicine.

[6]  L. Frich,et al.  Classification and identification of opioid addiction in chronic pain patients , 2010, European journal of pain.

[7]  H. Breivik,et al.  A 6-months, randomised, placebo-controlled evaluation of efficacy and tolerability of a low-dose 7-day buprenorphine transdermal patch in osteoarthritis patients naïve to potent opioids , 2010, Scandinavian journal of pain.

[8]  T. V. van Staa,et al.  Utilization characteristics and treatment persistence in patients prescribed low-dose buprenorphine patches in primary care in the United Kingdom: a retrospective cohort study. , 2009, Clinical therapeutics.

[9]  H. Kress.  Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine , 2009, European journal of pain.

[10]  N. Vadivelu,et al.  Management of chronic pain in the elderly: focus on transdermal buprenorphine , 2008, Clinical interventions in aging.

[11]  A. Dahan,et al.  Opioids and the Management of Chronic Severe Pain in the Elderly: Consensus Statement of an International Expert Panel with Focus on the Six Clinically Most Often Used World Health Organization step III Opioids (Buprenorphine, Fentanyl, Hydromorphone, Methadone, Morphine, Oxycodone) , 2008, Pain practice : the official journal of World Institute of Pain.

[12]  John Lewis,et al.  What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review. , 2008, Pain medicine.

[13]  Anders Sundström,et al.  The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six months , 2007, Pharmacoepidemiology and drug safety.

[14]  R. Sittl,et al.  Long-term management of chronic pain with transdermal buprenorphine: a multicenter, open-label, follow-up study in patients from three short-term clinical trials. , 2006, Clinical therapeutics.

[15]  B. Collett,et al.  Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment , 2006, European journal of pain.

[16]  K. Moriyama,et al.  Age-Dependent Opioid Escalation in Chronic Pain Patients , 2005, Anesthesia and analgesia.

[17]  E. Kalso,et al.  Opioids in chronic non-cancer pain: systematic review of efficacy and safety , 2004, Pain.

[18]  J. Mao,et al.  Opioid therapy for chronic pain. , 2003, The New England journal of medicine.